Join BOPA
Back to news articles

SURVEY: Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma

By BOPA research committee on 10th February 2025

Help Improve Bispecific Antibody Delivery for Multiple Myeloma Patients!

The Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma was published November 2024. Created by the Equity in Multiple Myeloma Bispecific Research and Access (EMMBRAce) Bispecific Antibody Implementation Group, aims to enhance the delivery and accessibility of bispecific antibodies for patients with multiple myeloma.

 

📄 Read the Consensus Framework here: Consensus Framework Document 

 

The EMMBRAce group would like your feedback to refine this framework and project, ultimately improving treatment options for patients. Please take a moment to complete the survey and share it with your network.

 

🗓️ Survey Closes: February 27th

 

🔗 Take the Survey: https://qualtrics.ucl.ac.uk/jfe/form/SV_0Ilnj2WKuNB9lEa

 

Thank you for your valuable input and support!

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article